國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Antimicrobial peptidesbasics for cli...

Matsuzaki, Katsumi.

Antimicrobial peptidesbasics for clinical application /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Antimicrobial peptidesedited by Katsumi Matsuzaki.
其他題名:	basics for clinical application /
其他作者:	Matsuzaki, Katsumi.
出版者:	Singapore :Springer Singapore :2019.
面頁冊數:	viii, 304 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Peptide antibiotics.
電子資源:	https://doi.org/10.1007/978-981-13-3588-4
ISBN:	9789811335884$q(electronic bk.)

Antimicrobial peptidesbasics for clinical application /
Antimicrobial peptidesbasics for clinical application /[electronic resource] :edited by Katsumi Matsuzaki. - Singapore :Springer Singapore :2019. - viii, 304 p. :ill. (some col.), digital ;24 cm. - Advances in experimental medicine and biology,v.11170065-2598 ;. - Advances in experimental medicine and biology ;946..

Part 1. Introduction -- Chapter 1. Antimicrobial peptides of multicellular organisms: My perspective -- Part 2. Mechanisms of Antimicrobial Action -- Chapter 2. Membrane permeabilization mechanisms -- Chapter 3. Elementary processes and mechanisms of interactions of antimicrobial peptides with membranes --- single GUV studies ---- -- Chapter 4. The mechanisms of action of cationic antimicrobial peptides refined by novel concepts from biophysical investigations -- Chapter 5. Anionic lipid clustering model -- Chapter 6. Intracellular antimicrobial peptides targeting the protein synthesis machinery -- Part 3. Other activities of AMPs -- Chapter 7. Antimicrobial and cell-penetrating peptides: How to understand two distinct functions despite similar physicochemical properties -- Chapter 8. Synthetic anti-lipopolysaccharide peptides (SALP) as effective inhibitors of pathogen-associated molecular patterns (PAMPs) -- Chapter 9. Anti-cancer activities of natural and synthetic peptides -- Chapter 10. Antimicrobial host defence peptides: Immunomodulatory functions and translational prospects -- Part 4. Towards Clinical Applications -- Chapter 11. Activity and selectivity of antimicrobial peptides: A complex interplay of multiple equilibria -- Chapter 12. Design of antimicrobial peptides: Progress made with human cathelicidin LL-37 -- Chapter 13. Application of synthetic molecular evolution to the discovery of antimicrobial peptides -- Chapter 14. AMPs as anti-biofilm agents for human therapy and prophylaxis -- Chapter 15. Clinical application of AMPs.

This book presents an overview of antimicrobial peptides (AMPs), their mechanisms of antimicrobial action, other activities, and various problems that must still be overcome regarding their clinical application. Divided into four major parts, the book begins with a general overview of AMPs (Part I), and subsequently discusses the various mechanisms of antimicrobial action and methods for researching them (Part 2) It then addresses a range of activities other than antimicrobial action, such as cell penetration, antisepsis, anticancer, and immunomodulatory activities (Part 3), and explores the prospects of clinical application from various standpoints such as the selective toxicity, design, and discovery of AMPs (Part 4) A huge number of AMPs have been discovered in plants, insects, and vertebrates including humans, and constitute host defense systems against invading pathogenic microorganisms. Consequently, many attempts have been made to utilize AMPs as antibiotics. AMPs could help to solve the urgent problem of drug-resistant bacteria, and are also promising with regard to sepsis and cancer therapy. Gathering a wealth of information, this book will be a bible for all those seeking to develop antibiotics, anti-sepsis, or anticancer agents based on AMPs.

ISBN: 9789811335884$q(electronic bk.)

Standard No.: 10.1007/978-981-13-3588-4doiSubjects--Topical Terms:

211092
Peptide antibiotics.

LC Class. No.: RS431.P37 / A585 2019

Dewey Class. No.: 615.7922

Antimicrobial peptidesbasics for clinical application /
LDR:03932nmm a2200337 a 4500 001 556623
003 DE-He213
005 20190916091235.0
006 m d
007 cr nn 008maaau
008 191127s2019 si s 0 eng d
020 $a 9789811335884$q(electronic bk.)
020 $a 9789811335877$q(paper)
024 7 $a 10.1007/978-981-13-3588-4 $2 doi
035 $a 978-981-13-3588-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.P37 $b A585 2019
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.7922 $2 23
090 $a RS431.P37 $b A631 2019
245 0 0 $a Antimicrobial peptides $h [electronic resource] : $b basics for clinical application / $c edited by Katsumi Matsuzaki.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a viii, 304 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1117
505 0 $a Part 1. Introduction -- Chapter 1. Antimicrobial peptides of multicellular organisms: My perspective -- Part 2. Mechanisms of Antimicrobial Action -- Chapter 2. Membrane permeabilization mechanisms -- Chapter 3. Elementary processes and mechanisms of interactions of antimicrobial peptides with membranes --- single GUV studies ---- -- Chapter 4. The mechanisms of action of cationic antimicrobial peptides refined by novel concepts from biophysical investigations -- Chapter 5. Anionic lipid clustering model -- Chapter 6. Intracellular antimicrobial peptides targeting the protein synthesis machinery -- Part 3. Other activities of AMPs -- Chapter 7. Antimicrobial and cell-penetrating peptides: How to understand two distinct functions despite similar physicochemical properties -- Chapter 8. Synthetic anti-lipopolysaccharide peptides (SALP) as effective inhibitors of pathogen-associated molecular patterns (PAMPs) -- Chapter 9. Anti-cancer activities of natural and synthetic peptides -- Chapter 10. Antimicrobial host defence peptides: Immunomodulatory functions and translational prospects -- Part 4. Towards Clinical Applications -- Chapter 11. Activity and selectivity of antimicrobial peptides: A complex interplay of multiple equilibria -- Chapter 12. Design of antimicrobial peptides: Progress made with human cathelicidin LL-37 -- Chapter 13. Application of synthetic molecular evolution to the discovery of antimicrobial peptides -- Chapter 14. AMPs as anti-biofilm agents for human therapy and prophylaxis -- Chapter 15. Clinical application of AMPs.
520 $a This book presents an overview of antimicrobial peptides (AMPs), their mechanisms of antimicrobial action, other activities, and various problems that must still be overcome regarding their clinical application. Divided into four major parts, the book begins with a general overview of AMPs (Part I), and subsequently discusses the various mechanisms of antimicrobial action and methods for researching them (Part 2) It then addresses a range of activities other than antimicrobial action, such as cell penetration, antisepsis, anticancer, and immunomodulatory activities (Part 3), and explores the prospects of clinical application from various standpoints such as the selective toxicity, design, and discovery of AMPs (Part 4) A huge number of AMPs have been discovered in plants, insects, and vertebrates including humans, and constitute host defense systems against invading pathogenic microorganisms. Consequently, many attempts have been made to utilize AMPs as antibiotics. AMPs could help to solve the urgent problem of drug-resistant bacteria, and are also promising with regard to sepsis and cancer therapy. Gathering a wealth of information, this book will be a bible for all those seeking to develop antibiotics, anti-sepsis, or anticancer agents based on AMPs.
650 0 $a Peptide antibiotics. $3 211092
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Biological and Medical Physics, Biophysics. $3 759746
650 2 4 $a Biochemistry, general. $3 273649
650 2 4 $a Cancer Research. $3 273660
700 1 $a Matsuzaki, Katsumi. $3 838849
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-981-13-3588-4
950 $a Biomedical and Life Sciences (Springer-11642)